Clinical Trial Update: DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a DPP-4 inhibitor to treat post-stroke cognitive impairment in patients with ischemic stroke and type 2 diabetes mellitus; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Ischemic Stroke, Diabete Mellitus | Phase 3 | Status: NOT_YET_RECRUITING